Elizabeth Jeffords has joined Alkahest as chief commercial and strategy officer. Jeffords comes to the San Carlos, CA, biotech from Roche subsidiary Genentech, where she was vice president of the unit’s U.S. ophthalmology portfolio. Alkahest develops therapies for age-related diseases. The company’s pipeline includes drug candidates for Alzheimer’s disease and age-related macular degeneration.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
